Magnetic resonance imaging in the prediction of aggressive histological features in papillary thyroid carcinoma.

Medicine (Baltimore)

Department of Radiology Department of Pathology Department of General Surgery, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China.

Published: June 2018

To identify magnetic resonance imaging (MRI) features in the prediction of tumor aggressiveness in patients with papillary thyroid carcinoma (PTC).In this prospective study, 105 patients with 122 PTCs underwent MRI with T1-weighted, T2-weighted, diffusion-weighted imaging and contrast-enhanced sequences prior to thyroidectomy. Based on exclusion criteria, 62 patients with 62 PTCs were finally suitable for further analysis. Tumor aggressiveness was defined according to the surgical histopathology. Tumor size, apparent diffusion coefficients (ADC) value and MRI features on images were obtained for each patient. Descriptive statistics for tumor aggressiveness, sensitivity, specificity, and accuracy of individual features were determined. A multivariate logistic regression model was developed to identify features that were independently predictive for tumor aggressiveness. Analyses of receiver-operating characteristic (ROC) curve were performed.High aggressive PTC significantly differed from low aggressive PTC in size (P = .016), size classification (P < .001), ADC value (P = .01), angulation on the lateral surface of the lesion (P = .009), signal intensity heterogeneity on ADC maps (P = .003), early enhancement degree (P < .001), tumor margin on delayed contrast-enhanced images (P < .001), and inner lining of delayed ring enhancement (P = .028). The interobserver agreement between the 2 readers was satisfactory with Cohen k ranging from 0.83 to 1.00 (P < .001). Logistic regression model showed lesion size classification and tumor margin on delayed contrast-enhanced images as strongest independent predictors of high aggressive PTC (P = .009 and P = .047), with an accuracy of 83.9%. The area under ROC curve for ADC value and lesion size were 0.68 and 0.81, respectively.These findings suggest that MRI before surgery has the potential to discriminate tumor aggressiveness in patients with PTC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039645PMC
http://dx.doi.org/10.1097/MD.0000000000011279DOI Listing

Publication Analysis

Top Keywords

tumor aggressiveness
16
magnetic resonance
8
resonance imaging
8
papillary thyroid
8
thyroid carcinoma
8
mri features
8
aggressive ptc
8
features
5
tumor
5
imaging prediction
4

Similar Publications

Melanoma is an aggressive tumor that is challenging to treat. Talimogene laherparepvec (T-VEC), the first oncolytic virus treatment approved by the US Food and Drug Administration to treat unresectable melanoma, was recently used in recurrent tumors after initial surgery. Our network meta-analysis aimed to compare T-VEC treatment of metastatic melanoma with treatment of granulocyte-macrophage colony-stimulating factor (GM-CSF) and control group.

View Article and Find Full Text PDF

Introduction: Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with delayed diagnosis often limiting effective treatment options. This study introduces a novel, non-invasive radiomics-based approach utilizing [18F] FDG PET/CT to predict VEGF status and survival in GC patients. The ability to non-invasively assess these parameters can significantly influence therapeutic decisions and outcomes.

View Article and Find Full Text PDF

Cancer and its diverse variations pose one of the most significant threats to human health and well-being. One of the most aggressive forms is blood cancer, originating from bone marrow cells and disrupting the production of normal blood cells. The incidence of blood cancer is steadily increasing, driven by both genetic and environmental factors.

View Article and Find Full Text PDF

Background: Tumour deposits are a prognostic factor for overall survival and distant metastasis in lymph node-negative colorectal cancer. However, the current TNM staging system does not account for the presence of tumour deposits in lymph node-positive colorectal cancer, or for the presence of multiple deposits. This study aimed to investigate the prognostic effect of tumour deposit count in patients with colorectal cancer.

View Article and Find Full Text PDF

Risk factors and protective measures for desmoid tumours in familial adenomatous polyposis: retrospective cohort study.

BJS Open

December 2024

Unit of Hereditary Digestive Tract Tumours, Fondazione IRCCS Istituto Nazionale dei Tumouri, Milan, Italy.

Background: Familial adenomatous polyposis is a cancer-predisposing syndrome caused by germline pathogenic variants of the adenomatous polyposis coli gene, leading to numerous colorectal polyps and a high risk of colorectal cancer. Desmoid tumours have become significant in the management of familial adenomatous polyposis after a colectomy, yet the exact incidence remains undetermined due to a lack of dedicated surveillance.

Methods: This retrospective study accessed data from the prospectively maintained Hereditary Digestive Tumours Registry from 2000 to 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!